Myosin light chain kinase
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | |||
<StructureSection load='2x4f' size='350' side='right' caption='Two monomers of human myosin light chain kinase residues 40-388 complex with pyrimidine derivative, pentaethylene glycol, ethanediol and sulfate ion (PDB entry [[2x4f]])' scene=''> | <StructureSection load='2x4f' size='350' side='right' caption='Two monomers of human myosin light chain kinase residues 40-388 complex with pyrimidine derivative, pentaethylene glycol, ethanediol and sulfate ion (PDB entry [[2x4f]])' scene=''> | ||
Line 10: | Line 9: | ||
==3D structures of MLCK== | ==3D structures of MLCK== | ||
- | [[ | + | [[2x4f]] – hMLCK residues 40-388 - human<br /> |
- | [[2yr3]] - hMLCK 4th Ig-like domain – NMR<br /> | + | [[6c6m]] - hMLCK 3rd Ig-like domain residues 405-507<br /> |
- | [[ | + | [[2yr3]] - hMLCK 4th Ig-like domain residues 510-601 – NMR<br /> |
+ | [[2cqv]] – hMLCK 8th Ig-like domain residues 1238-1338 – NMR<br /> | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 10:23, 5 November 2019
|
3D structures of MLCK
2x4f – hMLCK residues 40-388 - human
6c6m - hMLCK 3rd Ig-like domain residues 405-507
2yr3 - hMLCK 4th Ig-like domain residues 510-601 – NMR
2cqv – hMLCK 8th Ig-like domain residues 1238-1338 – NMR
References
- ↑ Stull JT, Tansey MG, Tang DC, Word RA, Kamm KE. Phosphorylation of myosin light chain kinase: a cellular mechanism for Ca2+ desensitization. Mol Cell Biochem. 1993 Nov;127-128:229-37. PMID:7935354
- ↑ Flores C, Ma SF, Maresso K, Ober C, Garcia JG. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans. Genet Epidemiol. 2007 May;31(4):296-305. PMID:17266121 doi:http://dx.doi.org/10.1002/gepi.20210
- ↑ Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest. 2005 Oct;115(10):2702-15. Epub 2005 Sep 22. PMID:16184195 doi:http://dx.doi.org/10.1172/JCI24970